Tonix Pharmaceuticals Holding TNXP Growth Metrics (2012-2026)

NASDAQ TNXP
$13.14 -0.23 (-1.72%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Tonix Pharmaceuticals Holding Quarterly Growth Metrics

Periods 50 quarters
Latest Jun 2026

Tonix Pharmaceuticals Holding growth metrics data for the quarter ended Jun 2026. These growth metrics cover 50 quarters of results from Mar 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Dec2017 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y)
-0.03M0.01M-0.27M0.02M-0.01M0.02M0.21M-0.05M-0.00M0.01M0.11M
EBITDA Margin Growth (3y)
-0.09M-0.02M0.05M
EBITDA Margin (QoQ)
-0.03M0.01M-0.00M-0.01M-0.26M0.30M-0.03M0.02M-0.08M0.04M0.01M0.03M0.03M
EBIT Margin Growth (1y)
-0.03M0.01M-0.27M0.02M-0.01M0.02M0.21M-0.05M-0.00M0.01M0.11M
EBIT Margin Growth (3y)
-0.09M-0.02M0.05M
EBIT Margin (QoQ)
-0.03M0.01M-0.00M-0.01M-0.26M0.30M-0.03M0.02M-0.08M0.04M0.01M0.03M0.03M
EBT Margin Growth (1y)
-0.03M0.01M-0.27M0.01M-0.02M0.02M0.21M-0.04M0.00M0.01M0.11M
EBT Margin Growth (3y)
-0.09M-0.02M0.05M
EBT Margin (QoQ)
-0.03M0.01M-478.00-0.02M-0.26M0.29M-0.03M0.02M-0.07M0.04M0.01M0.03M0.03M
FCF Margin Growth (1y)
0.00M0.03M0.03M-0.00M0.00M0.00M-0.03M-0.02M-0.02M0.00M0.05M
FCF Margin Growth (3y)
-0.00M-0.00M0.04M
FCF Margin (QoQ)
-0.01M0.01M0.00M-0.01M0.03M-0.02M0.01M-0.01M-0.01M-0.01M0.01M0.01M0.04M
Gross Margin Growth (1y)
441.000.00M0.00M-0.00M0.00M0.00M0.00M0.02M
Gross Margin (QoQ)
-312.00-425.00-0.01M0.01M929.00699.00-0.01M0.01M0.00M-331.000.00M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-55.37%
Net Margin Growth (1y)
-0.02M0.01M-0.28M0.02M-0.01M-0.01M0.22M-0.05M-0.00M0.01M0.11M
Net Margin Growth (3y)
-0.08M-0.02M0.05M
Net Margin (QoQ)
-0.02M0.01M-0.00M0.01M-0.30M0.31M-0.04M0.02M-0.07M0.04M0.01M0.03M0.03M
Operating Margin Growth (1y)
-0.03M0.01M-0.27M0.02M-0.01M0.02M0.21M-0.05M-0.00M0.01M0.11M
Operating Margin Growth (3y)
-0.09M-0.02M0.05M
Operating Margin (QoQ)
-0.03M0.01M-0.00M-0.01M-0.26M0.30M-0.03M0.02M-0.08M0.04M0.01M0.03M0.03M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M312.0023.00-218.00-656.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-149.000.01M0.01M0.01M0.00M-0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.01M0.01M0.01M0.01M0.02M0.02M0.01M995.00-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M-386.00-272.00108.00302.00988.00
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.01M0.00M0.00M-558.000.00M0.01M0.00M0.00M0.00M0.00M-937.00-0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-20.00-102.00-170.00314.00-260.00-540.00-0.00M-0.00M-897.00194.00696.00-0.01M-0.00M0.01M0.00M0.00M-146.00-161.00-870.00-784.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M226.00-65.00-219.00-711.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.00M577.000.01M0.02M0.01M0.00M-0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.01M0.01M0.01M0.01M0.02M0.03M0.01M898.00-0.00M-0.00M-0.00M-0.01M-0.02M-0.01M-0.00M-638.00-600.00-183.00-40.00949.00
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.01M0.00M0.00M-0.00M0.00M0.02M0.01M0.00M0.00M0.00M-0.00M-0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-91.00-274.00-39.00339.00-245.00-766.00-0.00M-0.00M-0.00M144.00744.00-0.01M-0.00M0.01M0.00M0.00M-207.00-349.00-983.00-990.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.03M0.01M-0.27M0.02M-0.01M0.02M0.21M-0.05M-0.00M0.01M0.11M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.09M-0.02M0.05M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.03M0.01M-0.00M-0.01M-0.26M0.30M-0.03M0.02M-0.08M0.04M0.01M0.03M0.03M